Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6629 record(s)

Req # A-2024-000709

Adverse Drug Reactions (ADRs) for Leuprorelin. Report numbers: E2B_07188885, E2B_07092960, E2B_06021856, E2B_07038917, E2B_07217419, E2B_07232658, E2B_07172403, E2B_07079902, E2B_06996278, E2B_06794352.

Organization: Health Canada

89 page(s)
November 2024

Req # A-2024-000815

Adverse Drug Reaction (ADR) for Alburex-5. Report number: 001080447.

Organization: Health Canada

5 page(s)
November 2024

Req # A-2024-000830

Adverse Drug Reactions (ADRs). Report numbers: 001099702, 001099704, 001099715, 001100430, 001100727, 001102701, 001102703 and 001102831.

Organization: Health Canada

47 page(s)
November 2024

Req # A-2024-000841

Adverse Drug Reactions (ADRs). Report numbers: 001100338, 001097998.

Organization: Health Canada

9 page(s)
November 2024

Req # A-2024-000849

Adverse Drug Reaction (ADR). Report number: 001064176.

Organization: Health Canada

5 page(s)
November 2024

Req # A-2024-000869

Adverse Drug Reaction (ADR). Report number: E2B_06286466.

Organization: Health Canada

41 page(s)
November 2024

Req # A-2024-000874

Adverse Drug Reaction (ADR) for ITULATEK. Report number: 001082464.

Organization: Health Canada

2 page(s)
November 2024

Req # A-2024-000875

Adverse Drug Reaction (ADR). Report number: E2B_07102854.

Organization: Health Canada

2763 page(s)
November 2024

Req # A-2024-000882

Adverse Drug Reaction (ADR). Report number: 001084670.

Organization: Health Canada

7 page(s)
November 2024

Req # A-2024-000884

Adverse Drug Reaction (ADR). Report number: 001081844.

Organization: Health Canada

42 page(s)
November 2024
Date modified: